4//SEC Filing
Burkhardt Glen 4
Accession 0001169245-21-000125
CIK 0001169245other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:50 PM ET
Size
6.5 KB
Accession
0001169245-21-000125
Insider Transaction Report
Form 4
Burkhardt Glen
VP, Human Resources
Transactions
- Award
Common Stock
2021-11-19$2.01/sh+5,766$11,590→ 5,766 total - Sale
Common Stock
2021-11-19$2.37/sh−5,766$13,665→ 0 total
Footnotes (2)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001803271
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 6:50 PM ET
- Size
- 6.5 KB